human
ill
affect
men
women
differ
gener
proport
individu
infect
sever
infect
higher
male
femal
viral
bacteri
fungal
parasit
diseas
howev
preval
sexual
transmit
infect
sti
hiv
herp
simplex
natur
review
immunolog
volum
septemb
higher
among
women
addit
mani
autoimmun
diseas
affect
women
men
system
lupu
erythematosu
sle
grave
diseas
hashimoto
thyroid
syndrom
exhibit
femal
male
predomin
multipl
sclerosi
rheumatoid
arthriti
scleroderma
femal
male
ratio
contrast
ankylos
spondyl
goodpastur
syndrom
reiter
syndrom
vascul
occur
predominantli
male
sexbas
differ
diseas
consequ
genet
differ
attribut
xchromosom
inactiv
differ
express
steroid
hormon
differ
anatomi
gender
life
experi
consequ
fail
includ
sexbas
differ
studi
design
analys
effect
led
onedrug
treatment
regimen
men
women
result
bia
differ
drug
efficaci
sideeffect
profil
reportedli
led
withdraw
eight
ten
prescript
drug
unit
state
market
specif
owe
health
issu
women
underrepresent
femal
clinic
studi
result
dispar
understand
treatment
diseas
individu
sex
certainli
exampl
specif
clinic
trial
proport
male
femal
studi
particip
reflect
preval
condit
studi
gener
popul
exampl
femal
male
particip
enrol
clinic
trial
antidepress
antiinflammatori
drug
wherea
primarili
male
particip
age
year
enrol
clinic
trial
drug
cardiovascular
diseas
howev
even
studi
femal
male
particip
allow
analysi
safeti
efficaci
therapi
sex
predispos
sex
inadequ
emphasi
place
identif
pharmacokinet
differ
male
femal
box
among
femal
differ
phase
ovarian
cycl
histor
underrepresent
women
clinic
trail
understand
food
drug
administr
fda
guidelin
explicitli
prohibit
particip
women
childbear
potenti
phase
earli
phase
clinic
trial
fda
made
two
chang
polici
studi
evalu
drug
women
first
sexspecif
analys
safeti
efficaci
test
drug
requir
second
longer
recommend
women
childbear
potenti
restrict
particip
earli
drug
trial
nation
institut
health
nih
revit
act
requir
nihfund
clinic
trial
includ
women
subject
fda
mandat
new
drug
applic
must
includ
data
safeti
effect
drug
sex
far
howev
inadequ
complianc
polici
highli
probabl
ad
econom
cost
expand
clinic
trial
includ
xfile
immun
sexbas
differ
predispos
immun
respons
abstract
despit
accumul
evid
support
sexbas
differ
innat
adapt
immun
respons
suscept
infecti
diseas
preval
autoimmun
diseas
health
research
clinic
practic
address
distinct
research
studi
immun
respons
stratifi
sex
xlink
gene
hormon
societ
context
among
mani
factor
contribut
dispar
immun
respons
male
femal
crucial
address
sexbas
differ
diseas
pathogenesi
pharmacokinet
pharmacodynam
therapeut
medic
provid
optim
diseas
manag
sex
pharmacokinet
describ
relationship
dosag
drug
concentr
time
blood
plasma
cell
tissu
factor
influenc
pharmacokinet
includ
bioavail
distribut
metabol
excret
sexbas
differ
gastric
empti
influenc
bioavail
bodi
composit
bodi
weight
bodi
fat
plasma
volum
organ
blood
flow
influenc
distribut
hepat
enzym
metabol
drug
influenc
drug
metabol
renal
clearanc
influenc
drug
excret
contribut
sexbas
differ
pharmacokinet
pharmacodynam
relat
pharmacokinet
paramet
pharmacolog
effect
sexbas
differ
pharmacodynam
distinguish
sexbas
differ
pharmacokinet
base
evid
plasma
concentr
drug
male
femal
necessarili
result
pharmacolog
outcom
appropri
number
women
includ
women
differ
hormon
phase
afford
suffici
power
detect
sexbas
differ
pharmacokinet
clinic
respons
main
factor
behind
noncompli
perspect
review
sexbas
differ
immun
respons
context
autoimmun
diseas
viral
infect
discuss
implic
clinic
signific
issu
drug
develop
effect
health
care
x
chromosom
diseas
x
chromosom
encod
approxim
gene
distinct
fewer
gene
express
chromosom
fig
priori
express
uniqu
ylink
gene
might
underli
sex
differ
diseas
suscept
notabl
recent
studi
transgen
mice
creat
compar
diseas
suscept
xx
xy
mice
common
gonad
type
reveal
xxchromosom
complement
confer
greater
suscept
sle
experiment
autoimmun
encephalomyel
eae
mous
model
multipl
sclerosi
compar
xychromosom
complement
contrast
normal
male
vulner
xlink
diseas
singl
x
chromosom
wherea
femal
two
provid
ad
biolog
advantag
cellular
mosaic
associ
xinactiv
importantli
human
outbr
speci
therefor
exhibit
allel
divers
xchromosom
natur
review
immunolog
figur
gene
x
chromosom
potenti
influenc
immunocompet
sever
protein
encod
gene
found
x
chromosom
might
underli
sexbas
differ
immun
respons
protein
list
select
identifi
gene
x
chromosom
group
accord
associ
function
receptor
associ
protein
protein
relat
immun
respons
b
protein
involv
transcript
translat
control
c
protein
definit
andor
known
function
list
protein
mark
asterisk
indic
encod
gene
also
found
chromosom
gene
contrast
inbr
mice
matern
patern
xchromosom
gene
ident
result
mutat
matern
xchromosom
gene
might
exist
patern
xchromosom
gene
human
xchromosom
inactiv
provid
dosag
compens
xlink
gene
xx
femal
xy
male
random
process
one
two
x
chromosom
transcript
silenc
earli
femal
develop
lead
mosaic
express
either
matern
xm
patern
xp
x
chromosom
differ
cell
popul
thu
result
xinactiv
potenti
half
cell
express
xlink
gene
mutat
femal
wherea
cell
male
express
xlink
gene
mutat
exampl
mutat
subunit
common
receptor
interleukin
caus
xlink
sever
combin
immunodefici
xscid
diseas
origin
identifi
famili
genet
relat
male
male
immunecel
lineag
normal
express
receptor
subunit
harbour
xlink
gene
mutat
wherea
xinactiv
femal
provid
restrict
express
mutat
therebi
diminish
extent
immun
defici
ipex
immun
dysregul
polyendocrinopathi
enteropathi
xlink
syndrom
rare
inflammatori
diseas
caus
mutat
gene
encod
transcript
regul
forkhead
box
destroy
immunoregulatori
environ
affect
male
infant
without
function
protein
regulatori
reg
cell
develop
normal
immun
suppress
mediat
subset
cell
absent
xinactiv
give
femal
protect
ipex
although
cell
male
express
display
mutat
normal
reg
cell
express
wildtyp
gene
suffici
maintain
homeostasi
femal
heterozyg
femal
metabol
cooper
contribut
ad
advantag
specif
xlink
gene
encod
secret
protein
express
intact
gene
cell
allow
uptak
protein
null
cell
express
defect
gene
exampl
hunter
syndrom
lysosom
storag
diseas
result
sever
progress
symptom
affect
mani
organ
caus
defect
enzym
iduron
sulphatos
synthes
cell
carrier
femal
other
defect
mutant
cell
correct
transfer
iduron
sulphatas
wildtyp
cell
secret
function
enzym
accordingli
carrier
femal
usual
unaffect
xlink
iduron
sulphatas
gene
defect
skew
xinactiv
provid
anoth
advantag
heterozyg
femal
process
lead
select
wildtyp
cell
mutant
cell
exampl
nonrandom
inactiv
x
chromosom
carri
defect
wiskottaldrich
syndrom
gene
mutat
caus
lifethreaten
immunodefici
affect
male
occur
earlylineag
haematopoiet
cell
femal
carrier
therebi
prevent
diseas
although
skew
xinactiv
select
normal
cell
benefici
occur
major
instanc
extrem
skew
xinactiv
also
implic
aetiolog
autoimmun
diseas
scleroderma
skew
xinactiv
gene
involv
antigen
process
discret
cell
popul
thymu
dendrit
cell
dc
present
antigen
cell
undergo
select
might
affect
recognit
self
antigen
therebi
caus
loss
immunolog
toler
featur
mani
autoimmun
diseas
view
togeth
genet
contribut
xinactiv
effect
provid
femal
extens
repertoir
protein
potenti
divers
mani
physiolog
process
compar
male
howev
influenc
xinactiv
xlink
gene
mutat
diseas
suscept
complic
factor
specif
mutat
nonxlink
gene
associ
chromatin
remodel
transcript
translat
event
also
potenti
influenc
xinactiv
express
gene
x
chromosom
moreov
mutat
transcript
translat
gene
encod
x
chromosom
fig
could
influenc
gene
express
chromosom
sexbas
differ
immun
oestrogen
influenc
immunocompet
gener
rule
femal
exhibit
robust
cellmedi
humor
immun
respons
antigen
challeng
infect
vaccin
compar
male
oestrogen
also
known
oestriol
progesteron
testosteron
mediat
mani
sexbas
differ
immun
respons
oestrogen
exert
effect
bind
cognat
intracellular
receptor
two
subtyp
receptor
oestrogen
oestrogen
receptor
also
known
also
known
express
mani
type
immun
cell
includ
cell
b
cell
dendrit
cell
dc
macrophag
neutrophil
natur
killer
nk
cell
suggest
oestrogen
might
role
regul
immunocompet
fig
complex
transloc
nucleu
bind
distinct
errespons
element
promot
target
gene
therebi
regul
transcript
activ
addit
complex
might
regul
transcript
activ
gene
errespons
element
recruit
coregulatori
protein
activ
repress
transcript
interestingli
ligand
exert
differ
influenc
cours
eae
specif
treatment
either
ligand
bind
antiinflammatori
abrog
onset
eae
wherea
treatment
specif
ligand
neuroprotect
antiinflammatori
women
higher
tcell
number
men
reg
cell
frequenc
within
popul
undergo
profound
chang
ovarian
cycl
potenti
affect
immunoregul
reg
cell
number
increas
follicular
phase
menstrual
cycl
oestrogen
level
high
decreas
luteal
phase
oestrogen
level
low
fig
reg
cell
regul
size
peripher
tcell
pool
modul
immun
respons
infect
particip
mainten
selftoler
suppress
immun
respons
mediat
autoreact
cell
contribut
autoimmun
diseas
accordingli
variat
number
reg
cell
cours
menstrual
cycl
influenc
immun
respons
addit
reg
cell
function
deficit
implic
autoimmun
diseas
multipl
sclerosi
rheumatoid
arthriti
distinct
effect
reg
cell
number
oestrogen
affect
express
chemokin
receptor
cell
oestrogen
select
increas
express
respons
ccchemokin
receptor
cell
import
implic
tcell
home
context
infect
autoimmun
oestrogen
might
also
exert
biphas
effect
helper
h
cell
versu
h
differenti
specif
low
dose
oestrogen
associ
h
respons
enhanc
cellmedi
immun
wherea
high
dose
oestrogen
promot
h
humor
respons
interestingli
evid
suggest
contrast
effect
oestrogen
tbet
master
regul
h
differenti
interferon
regulatori
transcript
factor
associ
regul
may
dosedepend
account
h
versu
h
differenti
lower
level
oestrogen
might
contribut
increas
express
tbet
wherea
higher
level
might
downregul
express
ref
although
low
dose
oestrogen
associ
enhanc
express
h
cell
higher
dose
oestrogen
enhanc
product
addit
oestrogen
neg
regul
tcellderiv
tumournecrosi
factor
tnf
fig
influenc
oestrogen
h
cell
bia
exemplifi
hormon
environ
pregnanc
increas
oestrogen
progesteron
level
third
trimest
favour
gener
h
respons
notabl
oestriol
oestrogen
metabolit
deriv
placenta
produc
signific
amount
pregnanc
autoimmun
diseas
hormon
fluctuat
pregnanc
affect
diseas
activ
h
environ
contribut
enhanc
antibodi
product
exacerb
sle
wherea
suppress
h
respons
oestrogen
result
decreas
diseas
activ
patient
rheumatoid
arthriti
multipl
sclerosi
recent
evid
eae
model
suggest
decreas
diseas
activ
pregnanc
probabl
associ
immunoregulatori
environ
rather
suppress
h
respons
find
led
initi
sever
pilot
clinic
studi
examin
effect
oestriol
therapi
multipl
sclerosi
notabl
remiss
rheumatoid
arthriti
multipl
sclerosi
pregnanc
often
follow
flare
diseas
activ
postpartum
oestrogen
progesteron
level
fall
oestrogen
also
affect
bcell
develop
decreas
neg
select
naiv
immatur
b
cell
enhanc
surviv
autoreact
b
cell
enhanc
polyclon
activ
b
cell
lead
higher
serum
level
igg
igm
mediat
interact
bcell
effect
might
contribut
increas
incid
mani
autoimmun
diseas
women
effect
oestrogen
innat
immun
respons
mediat
monocyt
macrophag
larg
repress
also
known
receptor
express
monocyt
macrophag
activ
self
antigen
rheumatoid
factor
induc
signal
cascad
stimul
cytokin
product
oestrogen
modul
express
monocyt
macrophag
interact
promot
suppress
express
ref
consequ
oestrogen
reduc
monocyt
macrophag
product
proinflammatori
cytokin
tnf
vitro
addit
oestrogen
decreas
plasma
level
product
tnf
increas
luteal
phase
low
oestrogen
compar
follicular
high
oestrogen
phase
ovarian
cycl
addit
antiinflammatori
effect
monocyt
mediat
decreas
product
proinflammatori
cytokin
oestrogen
exert
antiinflammatori
effect
neutrophil
increas
nitricoxid
synthas
express
nitricoxid
product
addit
progesteron
enhanc
chemotact
activ
neutrophil
wherea
oestrogen
decreas
oestrogen
also
effect
innat
immun
cell
specif
oestrogen
decreas
cytotox
nk
cell
addit
recent
data
indic
oestrogen
also
regul
dc
develop
exposur
bonemarrow
dc
precursor
oestrogen
facilit
develop
convent
dc
secret
proinflammatori
furthermor
exposur
matur
splenic
dc
oestrogen
result
expans
killer
dc
mhc
class
ii
high
phenotyp
treatment
immatur
dc
increas
also
known
also
known
product
fig
low
oestrogen
level
reg
cell
number
express
tnf
product
dendrit
cell
differenti
cdc
bmdc
product
expans
killer
dc
matur
splenic
dc
express
immatur
dc
monocyt
macrophag
tnf
product
neutrophil
antiinflammatori
activ
chemotact
activ
figur
effect
immunocompet
activ
oestrogen
receptor
express
cell
b
cell
dendrit
cell
dc
macrophag
neutrophil
natur
killer
nk
cell
influenc
immunocompet
oestrogen
exert
biphas
effect
helper
h
cell
polar
low
level
promot
h
differenti
higher
level
promot
h
polar
consequ
effect
product
cytokin
associ
h
cell
popul
oestrogen
increas
size
reg
cell
popul
addit
oestrogen
increas
ccchemokin
receptor
express
decreas
tumournecrosi
factor
tnf
product
cell
oestrogen
decreas
neg
select
naiv
b
cell
enhanc
surviv
autoreact
b
cell
enhanc
polyclon
bcell
activ
immunoglobulin
product
inhibit
express
oestrogen
monocyt
macrophag
lead
reduc
product
proinflammatori
cytokin
tnf
neutrophil
oestrogen
upregul
product
nitricoxid
synthas
nitric
oxid
therebi
promot
antiinflammatori
effect
decreas
chemotact
activ
oestrogen
promot
differenti
convent
dc
cdc
bonemarrowderiv
dc
precursor
bmdc
increas
product
wherea
exposur
matur
splenic
dc
oestrogen
result
expans
produc
killer
dc
treatment
increas
secret
ccchemokin
ligand
immatur
dc
idc
oestrogen
also
reduc
cytotox
nk
cell
refer
fig
moreov
oestrogen
shape
immun
respons
affect
microvascular
endotheli
cell
activ
recruit
immun
inflammatori
cell
lymphoid
peripher
tissu
express
adhes
molecul
chemokin
specif
oestrogen
influenc
endothelialcel
function
differenti
regul
express
select
enhanc
express
adhes
molecul
chemokin
notabl
effect
androgen
testosteron
immun
function
larg
suppress
therebi
lead
decreas
tand
bcell
prolifer
decreas
immunoglobulin
cytokin
product
testosteron
decreas
express
macrophag
monocyt
tolllik
receptor
receptor
involv
activ
innat
immun
system
respons
pathogen
challeng
decreas
express
provid
potenti
underli
mechan
immunosuppress
effect
testosteron
also
worth
note
oestrogen
deriv
convers
androgen
aromatas
enzym
presenc
proinflammatori
cytokin
tnf
affect
tissu
individu
rheumatoid
arthriti
sle
associ
increas
aromatas
activ
correspond
acceler
synthesi
oestrogen
paracrin
effect
increas
oestrogen
level
affect
tissu
could
therebi
influenc
diseas
activ
affect
function
resid
cell
b
cell
monocyt
macrophag
describ
previous
howev
role
oestrogen
metabolit
proand
antiinflammatori
mediat
respect
chronic
inflammatori
diseas
remain
unclear
clearli
widespread
effect
oestrogen
progesteron
differ
immun
cell
implic
diseas
suscept
sex
howev
although
known
sex
differ
predispos
suscept
mani
autoimmun
diseas
distinguish
sexspecif
effect
sex
steroid
patholog
therapi
receiv
limit
attent
notabl
except
patient
multipl
sclerosi
testosteron
treatment
exhibit
potenti
neuroprotect
effect
men
relapsingremit
multipl
sclerosi
given
evid
diseas
remiss
pregnanc
potenti
neuroprotect
effect
er
ligand
treatment
strategi
offer
prospect
novel
therapi
women
multipl
sclerosi
effect
oestrogen
hormon
fluctuat
relat
reproduct
phase
immunecel
develop
function
cytokin
chemokin
product
migrat
cell
site
inflamm
influenc
immunocompet
accordingli
hormon
affect
pathogenesi
chronic
autoimmun
inflammatori
diseas
contribut
higher
incid
certain
autoimmun
diseas
women
addit
influenc
incid
progress
certain
autoimmun
diseas
sexbas
differ
affect
immunocompet
also
influenc
suscept
infect
sever
subsequ
ill
although
prevail
dogma
femal
typic
mount
robust
immun
respons
viral
infect
male
chang
hormon
concentr
owe
menstrual
cycl
contracept
usag
hormonereplac
therapi
pregnanc
influenc
immun
respons
pathogen
addit
men
women
also
differenti
suscept
sever
dna
rna
virus
hiv
measl
viru
hantavirus
vesicular
stomat
viru
vsv
howev
close
scrutini
scientif
literatur
reveal
scarciti
public
examin
sexbas
differ
human
viral
infecti
diseas
studi
carri
mice
rat
data
rodent
studi
howev
provid
insight
mechan
contribut
sexbas
differ
diseas
sever
coxsackieviru
infect
associ
myocard
although
men
women
equal
suscept
infect
cardioprotect
effect
oestrogen
link
lower
incid
heart
diseas
women
accumul
data
indic
differ
sever
myocard
sex
limit
differ
level
viral
replic
heart
attribut
differ
immun
respons
infect
higher
level
oestrogen
women
decreas
express
proinflammatori
cytokin
wherea
robust
proinflammatori
immun
respons
infect
male
increas
inflamm
heart
recent
data
mous
studi
suggest
oestrogen
mediat
decreas
number
mast
cell
macrophag
infect
heart
femal
associ
upregul
tcell
immunoglobulin
domain
mucin
also
natur
review
immunolog
known
cell
turn
inhibit
express
therebi
regul
inflammatori
respons
increas
size
reg
cell
popul
contrast
infect
male
heart
show
increas
number
mast
cell
macrophag
high
express
express
male
inhibit
downregul
inflammatori
respons
decreas
express
therebi
reduc
size
reg
cell
popul
inhibit
apoptosi
similar
infect
human
male
femal
rat
equal
suscept
infect
hantaviru
seoul
viru
femal
mount
robust
immun
respons
infect
result
decreas
viral
shed
lower
viral
load
target
organ
analysi
lung
hantavirusinfect
femal
rat
reveal
pattern
gene
express
associ
robust
innat
antivir
immun
respons
name
increas
level
gene
encod
microbi
pattern
recognit
receptor
ifninduc
signal
effector
compar
lung
infect
male
rat
human
studi
indic
male
femal
infect
hantavirus
perhap
indic
rigor
innat
immun
respons
identifi
infect
femal
rat
also
occur
human
moreov
hantavirusinfect
femal
significantli
higher
plasma
level
lower
level
proinflammatori
chemokin
male
support
exist
sexdepend
differ
immun
respons
viral
infect
studi
mice
suggest
sexbas
differ
suscept
viral
infect
central
nervou
system
cn
vsv
also
correspond
enhanc
immun
cn
femal
associ
recoveri
neurotrop
viral
infect
final
although
age
import
predictor
mortal
sever
acut
respiratori
syndrom
sar
viru
outbreak
femal
lower
mortal
rate
male
even
adjust
age
tempt
specul
robust
innat
antivir
immun
respons
femal
might
account
reduc
mortal
rate
contrast
dengu
viru
infect
sever
femal
children
male
children
one
possibl
explan
stronger
humor
immun
respons
viru
femal
might
link
develop
crossreact
nonneutr
antibodi
allow
viru
replic
proceed
uncheck
howev
herpesviru
infect
stronger
humor
immun
respons
exhibit
femal
advantag
men
like
women
seroneg
gammaherpesviru
epsteinbarr
viru
ebv
seroposit
women
higher
ebvspecif
antibodi
titr
seroposit
men
addit
women
infect
cytomegaloviru
cmv
produc
higher
level
cmvinfect
men
consist
robust
cellmedi
immun
respons
found
women
find
might
help
explain
femal
develop
protect
immun
viral
antigen
phase
iii
clinic
vaccin
trial
emphas
import
evalu
respons
sex
studi
world
health
organ
estim
one
million
new
case
sti
occur
daili
worldwid
hiv
common
sexual
transmit
viru
rate
transmiss
male
femal
greater
femal
male
contribut
higher
preval
sti
femal
suscept
mucos
surfac
femal
genit
tract
infect
hiv
influenc
oestrogen
progesteron
level
specif
progesteron
protect
decreas
viral
shed
wherea
oestrogen
increas
viral
shed
context
hiv
infect
level
viral
rna
plasma
consist
lower
women
men
given
initi
viral
load
seroconvers
predict
likelihood
progress
aid
men
women
higher
tcell
count
one
would
anticip
women
would
therefor
lower
risk
aid
howev
case
collect
find
indic
sexdepend
factor
influenc
suscept
numer
viral
infect
progress
sever
viral
infect
suscept
ident
among
men
women
howev
fluctuat
oestrogen
progesteron
level
directli
affect
immun
respons
mucos
tissu
therebi
influenc
femal
suscept
sexual
transmit
viral
infect
effect
oestrogen
cytokin
chemokin
product
promot
antiinflammatori
environ
offer
femal
protect
immunopatholog
associ
certain
viral
infect
notabl
chang
oestrogen
level
women
determin
ovarian
activ
directli
influenc
profil
immun
respons
low
oestrogen
level
associ
h
polar
respons
link
product
cytokin
antivir
activ
wherea
high
oestrogen
level
associ
h
polar
product
cytokin
promot
humor
immun
vigor
humor
immun
respons
femal
also
consequ
direct
effect
oestrogen
bcell
function
enhanc
neutral
antibodi
product
therebi
assist
viral
clearanc
impact
gender
differ
differ
mani
infectiousdiseas
process
men
women
aris
base
sex
gender
sex
refer
biolog
differ
male
femal
describ
previous
perspect
articl
wherea
gender
refer
differ
male
femal
determin
cultur
societ
factor
recent
joint
ventur
public
depart
gender
women
health
epidem
pandem
alert
respons
note
report
respons
relat
infecti
outbreak
rare
includ
data
gender
sex
differ
institut
medicin
suggest
assess
differ
incid
mani
infecti
diseas
male
femal
also
take
account
differ
diseas
exposur
perhap
compel
exampl
gender
signific
factor
diseas
suscept
relat
contextu
cultur
social
realiti
put
women
high
risk
contract
hiv
subsaharan
africa
anoth
interest
exampl
measl
infect
contract
child
opposit
sex
sever
infect
contract
child
sex
moreov
secondari
case
measl
home
sever
higher
mortal
rate
sever
secondari
case
may
relat
higher
viru
absorpt
associ
higher
infect
dose
certain
societi
fatal
rate
measl
case
higher
femal
male
girl
remain
home
therefor
higher
risk
infect
sibl
insid
home
addit
male
contract
diseas
outsid
home
pass
secondari
sever
infect
femal
remain
insid
home
greater
sever
also
associ
transmiss
sex
varicellazost
viru
caus
chickenpox
polio
viru
thu
increas
sever
infecti
diseas
femal
result
gender
rather
sex
differ
basi
new
therapeut
strategi
improv
diseas
manag
includ
learn
inform
hostpathogen
interact
increas
knowledg
regard
aetiolog
pathogenesi
individu
autoimmun
diseas
preced
discuss
illustr
sexbas
differ
immun
respons
contribut
diseas
suscept
sever
regul
part
interact
sex
steroid
hormon
immun
system
addit
role
sexchromosom
complement
determin
femal
bia
autoimmun
diseas
recogn
interestingli
evid
male
sexchromosom
complement
male
sex
hormon
might
certain
circumst
compensatori
effect
immun
respons
might
therebi
decreas
differ
immun
respons
male
femal
confer
sex
chromosom
alon
specif
compensatori
effect
sex
chromosom
complement
sex
hormon
autoantigenspecif
immun
respons
observ
studi
mice
defici
testisdetermin
sri
gene
allow
product
mice
differ
sexchromosom
complement
gonad
type
use
gonadectom
address
sex
hormon
influenc
except
howev
sexdepend
differ
immun
respons
infecti
pathogen
disregard
studi
autoimmun
account
sexrel
influenc
addit
studi
inbr
mice
address
contribut
allel
divers
gene
x
chromosom
male
femal
investig
sexbas
differ
immun
respons
use
mous
model
flaw
therefor
accur
analys
sexbas
differ
immun
respons
requir
examin
human
tissu
far
drug
develop
proceed
without
consider
sexbas
differ
diseas
suscept
sever
particularli
unfortun
identif
sexdepend
factor
could
reveal
potenti
new
therapeut
target
moreov
drug
develop
far
adequ
address
accumul
evid
suggest
sexbas
differ
affect
pharmacokinet
pharmacodynam
box
antiretrovir
therapi
hiv
exemplifi
variou
studi
drug
shown
women
frequent
seriou
advers
event
men
probabl
consequ
sexbas
differ
pharmacokinet
pharmacodynam
antiretrovir
drug
overal
women
greater
risk
suffer
advers
drug
reaction
medic
alreadi
market
result
underrepresent
clinic
trial
owe
lack
detail
pharmacokinet
pharmacodynam
studi
suffici
power
detect
sexbas
effect
publish
data
drug
efficaci
segreg
sex
also
lack
exampl
data
regard
sexbas
differ
viroimmunolog
outcom
hivinfect
men
women
antiretrovir
therapi
inconclus
larg
studi
underpow
detect
differ
togeth
data
indic
consequ
consid
sexbas
differ
human
ill
signific
unaccept
advent
human
tissu
biobank
opportun
investig
human
tissu
ex
vivo
examin
sexbas
differ
immun
respons
diseasespecif
tissu
biobank
individu
patient
provid
multipl
specimen
cours
diseas
offer
ad
advantag
allow
analysi
sexdepend
differ
context
hormon
fluctuat
femal
prospect
bank
therefor
requir
data
phase
menstrual
cycl
pregnanc
contracept
use
hormonereplac
therapi
must
acquir
tissu
specimen
collect
femal
futur
studi
must
address
sexbas
differ
immun
respons
infecti
autoimmun
diseas
aspect
scientif
inquiri
make
consider
prioriti
comprehens
effect
health
care
respons
resid
healthresearch
fund
agenc
includ
feder
govern
druglicens
agenc
insist
research
investig
stratifi
includ
sexdepend
analys
